Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 47

1.

Low use of statins for secondary prevention in primary care: a survey in a northern Swedish population.

Nilsson G, Samuelsson E, Söderström L, Mooe T.

BMC Fam Pract. 2016 Aug 11;17(1):110. doi: 10.1186/s12875-016-0505-0.

2.

Implementation of a new guideline in cardiovascular secondary preventive care: subanalysis of a randomized controlled trial.

Jakobsson S, Huber D, Björklund F, Mooe T.

BMC Cardiovasc Disord. 2016 Apr 30;16:77. doi: 10.1186/s12872-016-0252-0.

3.

Screening for Atrial Fibrillation--A Cross-Sectional Survey of Healthcare Professionals in Primary Care.

Taggar JS, Coleman T, Lewis S, Jones M.

PLoS One. 2016 Apr 1;11(4):e0152086. doi: 10.1371/journal.pone.0152086. eCollection 2016.

4.

Using drug sales data to evaluate the epidemiology of cardiometabolic risk factors and their inequality: an ecological study on atorvastatin and total cholesterol in Iran.

Ahmadvand A, Farzadfar F, Jamshidi HR, Mohammadi N, Holakouie-Naieni K.

Med J Islam Repub Iran. 2015 Sep 9;29:260. eCollection 2015.

5.

Global Cardiovascular Risk Assessment by Family Physicians in Suez Canal University-Family Medicine Centers-Egypt.

Nour-Eldein H, Abdelsalam SA, Nasr GM, Abdelwahed HA.

J Family Med Prim Care. 2013 Oct-Dec;2(4):365-70. doi: 10.4103/2249-4863.123919.

6.

Impact of treatment with rosuvastatin and atorvastatin on cardiovascular outcomes: evidence from the Archimedes-simulated clinical trials.

Colivicchi F, Sternhufvud C, Gandhi SK.

Clinicoecon Outcomes Res. 2015 Nov 27;7:555-65. doi: 10.2147/CEOR.S88817. eCollection 2015. Review.

7.

GPs' perspectives on secondary cardiovascular prevention in older age: a focus group study in the Netherlands.

van Peet PG, Drewes YM, Gussekloo J, de Ruijter W.

Br J Gen Pract. 2015 Nov;65(640):e739-47. doi: 10.3399/bjgp15X687373.

8.

Achievement of Target Blood Pressure Levels among Japanese Workers with Hypertension and Healthy Lifestyle Characteristics Associated with Therapeutic Failure.

Kudo N, Yokokawa H, Fukuda H, Sanada H, Miwa Y, Hisaoka T, Isonuma H.

PLoS One. 2015 Jul 30;10(7):e0133641. doi: 10.1371/journal.pone.0133641. eCollection 2015.

9.

Healthcare professionals' and policy makers' views on implementing a clinical practice guideline of hypertension management: a qualitative study.

Lee PY, Liew SM, Abdullah A, Abdullah N, Ng CJ, Hanafi NS, Chia YC, Lai PS, Wong SS, Khoo EM.

PLoS One. 2015 May 5;10(5):e0126191. doi: 10.1371/journal.pone.0126191. eCollection 2015.

10.

A web-based survey of residents' views on advocating with patients for a healthy built environment in Canada.

Cruickshank M, Law M.

Int J Family Med. 2014;2014:458184. doi: 10.1155/2014/458184. Epub 2014 Nov 11.

11.
12.

Home based telemedicine intervention for patients with uncontrolled hypertension--a real life non-randomized study.

Bernocchi P, Scalvini S, Bertacchini F, Rivadossi F, Muiesan ML.

BMC Med Inform Decis Mak. 2014 Jun 12;14:52. doi: 10.1186/1472-6947-14-52.

13.

Knowledge assessment regarding secondary prevention of coronary heart disease--a multi centre survey.

Matthias AT, Lokunarangoda NC, Ekanayaka R.

BMC Med Educ. 2014 Jun 6;14:113. doi: 10.1186/1472-6920-14-113.

14.

Modifying health behavior to prevent cardiovascular diseases: a nationwide survey among German primary care physicians.

Schneider S, Diehl K, Bock C, Herr RM, Mayer M, Görig T.

Int J Environ Res Public Health. 2014 Apr 15;11(4):4218-32. doi: 10.3390/ijerph110404218.

15.

Troponin T and N-terminal pro-B-type natriuretic peptide: a biomarker approach to predict heart failure risk--the atherosclerosis risk in communities study.

Nambi V, Liu X, Chambless LE, de Lemos JA, Virani SS, Agarwal S, Boerwinkle E, Hoogeveen RC, Aguilar D, Astor BC, Srinivas PR, Deswal A, Mosley TH, Coresh J, Folsom AR, Heiss G, Ballantyne CM.

Clin Chem. 2013 Dec;59(12):1802-10. doi: 10.1373/clinchem.2013.203638. Epub 2013 Sep 13.

16.

Cardiovascular risk scores: qualitative study of how primary care practitioners understand and use them.

Liew SM, Blacklock C, Hislop J, Glasziou P, Mant D.

Br J Gen Pract. 2013 Jun;63(611):e401-7. doi: 10.3399/bjgp13X668195.

17.

Only One Third of Tehran's Physicians are Familiar with 'Evidence-Based Clinical Guidelines'.

Mounesan L, Nedjat S, Majdzadeh R, Rashidian A, Gholami J.

Int J Prev Med. 2013 Mar;4(3):349-57.

18.

Implementation of Spanish adaptation of the European guidelines on cardiovascular disease prevention in primary care.

Brotons C, Lobos JM, Royo-Bordonada MÁ, Maiques A, de Santiago A, Castellanos Á, Diaz S, Obaya JC, Pedro-Botet J, Moral I, Lizarbe V, Moreno R, Pérez A, Cordero A, Fornés-Ubeda F, Serrano-Saiz B, Camafort-Babkowski M, Elosua R, Sans S, de Pablo C, Gil-Nuñez A, de Álvaro-Moreno F, Armario P, Rico OC, Villar F, Lizcano Á.

BMC Fam Pract. 2013 Mar 18;14:36. doi: 10.1186/1471-2296-14-36.

19.

Adherence to lipid-lowering treatment: the patient perspective.

Casula M, Tragni E, Catapano AL.

Patient Prefer Adherence. 2012;6:805-14. doi: 10.2147/PPA.S29092. Epub 2012 Nov 8.

Supplemental Content

Support Center